home Archives

Ultra-Fast COVID-19 results using NextGenPCR® in combination with FLUOstar Omega from BMG Labtech

Ultra-Fast COVID-19 results using NextGenPCR® from MBS in combination with FLUOstar Omega from BMG Labtech Saliva sampling is non-invasive and ideal for sites where repeat testing is required. In this application note from @BMG Labtech, the detection of SARS-CoV-2 in saliva was evaluated: NextGenPCR™ significantly accelerates testing down to 27 minutes Sensitive RT-PCR detection: less … Continue reading

12 May 2022

Wouldn’t it be great to see 2 minute PCR at the ECCMID 2022?

Molecular Biology Systems will be exhibiting at the 32nd edition of the ECCMID Conference from April 23-26, 2022 in Lisbon, Portugal. MBS is looking forward to meeting those attending. To learn more about NextGenPCR®, stop by Booth 1.40 any time during the exhibit… Continue reading

18 April 2022

Ultra fast high throughput COVID-19 by nextgenPCR at the Slovak Health Pitch

You are cordially invited to our session of lectures on Covid-19. Here we would like to present how we showcase Slovakia as an example where innovative preventive measures go hand in hand with innovative treatment measures. We look forward to meeting you. It is possible to discuss and ask questions… Continue reading

28 January 2022

Leading diagnostics laboratory in the Caribbean selects NextGenPCR for SARS-CoV-2 testing

6 April 2021

Ultrafast RT-PCR for COVID-19 by Molecular Biology Systems draws Dutch government support

Publication demonstrates updated NEXTGENPCR accelerates detection of SARS-CoV-2 RNA from clinical samples Goes, Netherlands, April 2, 2020 – Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced a publication detailing the use of its revolutionary NEXTGENPCR endpoint thermocycler to test for SARS-CoV-2 with a one-step reverse transcription polymerase chain reaction (RT-PCR) in 16 … Continue reading

30 June 2020

Dutch Firm Molecular Biology Systems Validating Rapid Thermal Cycler for COVID-19 Testing

Dutch company Molecular Biology Systems is in the process of validating its shoebox-sized NextGenPCR instrument for rapid SARS-CoV-2 diagnostic testing, claiming the system could potentially process more than 22,000 samples in a day by performing plate-based thermal cycling in less than eight minutes… Continue reading

30 June 2020

22,860 SARS-CoV-2 coronavirus tests in 24 hours with NEXTGENPCR

A single unit, the size of a shoebox, could perform a hundred and eighty (180) amplification runs a day, an almost ten-fold increase over the current US Centers for Disease Control (CDC) recommended instrumentation. Detection of amplified product can be done with widely-available blue light gel document systems… Continue reading

31 March 2020

MBS adds Velocidy Bio as distributor for US and Canada

Molecular Biology Systems (MBS), the developer of NEXTGENPCR®, is pleased to announce their newest distributor, Velocidy Bio. Velocidy Bio becomes the exclusive distributor of NEXTGENPCR® instruments, accessories and consumables in the United States and Canada. NEXTGENPCR® is an innovative thermal cycler that can reduce cycling programs to less than two minutes, by both eliminating ramp times as well as reducing dwell times… Continue reading

19 February 2020

NextGenPCR at the ASHG

Molecular Biology Systems will be exhibiting at this year’s American Society of Human Genetics Conference from October 15-19, 2019 in Houston, USA. MBS is looking forward to meeting those attending. To learn more about NextGenPCR, stop by Booth 107 any time during the exhibit… Continue reading

18 September 2019

Login

home